D
uring treatment with CAPD, proteins are lost in the peritoneal effluent (1) (2) (3) (4) (5) (6) (7) (8) . These are generally Correspondence to: D&eacute;sir&eacute;e Zemel, Renal Unit, F4-215, Academic Medical Center, Meibergdreef9, 1105 AZ Amsterdam, The Netherlands.
Received June 20, 1990 ; accepted November 5, 1990. believed to originate from the blood, although local synthesis cannot be excluded (6, 9) . Transperitoneal transport of low molecular weight solutes like urea and creatinine from blood to dialysate depends almost exclusively on effective peritoneal surface area (10) (11) (12) . The passage of high molecular weight solutes such as proteins is dependent both on effective peritoneal surface area and the intrinsic permeability of the peritoneal membrane (10) (11) (12) (13) . Changes in peritoneal transport have been studied intensively during episodes ofperitonitis (14, 15) and in response to intravenous or intraperitoneal administration of drugs (11, 16, 17) . However, little attention has been paid to the time course of peritoneal transport from day-to-day, as it occurs under normal circumstances. For mass transfer area coefficients (MTCs) oflow mo lecular weight solutes, coefficients of variation ranging from 15-20% have been reported (18) (19) (20) . Peritoneal clearances of proteins are often claimed to be constant after a period varying from 2 months to 2 years (5) (6) (7) (21) (22) (23) . Most of these studies, however, lack accurate information on coefficients of variation. Data from our previous studies (24, 25) indicated increasing variability of protein clearances when examined with longer intervals. We hypothesized that alterations in effective peritoneal surface area are the main cause of day-to-day changes in protein clearances. To test this hypothesis, we studied the day-to-day variability of the peritoneal clearances of 4 proteins in 4 CAPD patients over 28 consecutive days and determined the relative contributions of changes in effective surface area and intrinsic permeability.
METHODS
Four clinically stable CAPD patients (2 male, 2 female) were investigated. Primary renal diseases were chronic pyelonephritis in patient 1, adult polycystic kidney disease in patient 3 and hypertensive nephropathy in patients 2 and 4. Mean age was 47 years (range 34-65 ). Time on dialysis was 4 months in patient 1, 67 in patient 2 and 6 in patients 3 and 4. Only patient 2 had experienced peritonitis (rate 1.24 episodes/year), but was free of infection 25 months before, and during, the period of the study. Three patients (2, 3 and 4) were treated with 2-L dialysate bags; patient 1 was treated with 1.5-L bags (Baxter, DianeaIR). Patients were free to choose their appropriate glucose concentration. None of the patients used vasodilating, beta-blocking agents or other antihypertensives, except patient 3, who was treated with captopril 25 mg t.i.d. during the entire study period.
For 28 consecutive days, patients were asked to weigh each night bag after drainage and subsequently draw samples using a Venoject (Terumo, Louvain, Be lgium) system. These were immediately stored at -20°C. The length of the night dwell in our patients ranged from 7-11 hours; those of the exchanges preceding the night bags ranged from 4-6 hours. Serum samples were obtained once a week. The following proteins were measured: beta-2-microglobulin (molecular weight, MW 11,800), albumin (MW 69,000), IgG (MW 150,000) and alpha-2-macroglobulin (MW 820,000 
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Regression and c orrelation were determined by the method of least squares. To obtain overall corre lation coefficients, Fisher's Z-transformation was
RESULTS
The observation period consisted of 112 patient days. Of these 112 patient days, 3 had to be excluded because the patient had forgotten to draw dialysate samples from the night bag. For the remaining 109 patient days, peritoneal clearances were calculated for all proteins in each patient. Peritoneal clearances decreased from 808&plusmn;30 &mu;L/min for beta-2-microglobulin to 96&plusmn;15 &mu;L/min for albumin, 51&plusmn;12 &mu;L/min for IgG, and 11&plusmn;3 &mu;L/min for alpha-2-macroglobulin.
Considerable day-to-day changes in clearances existed for all proteins measured. This is demonstrated for 1 patient in Figure 1 . Coefficients of intraindividual variation in each patient are summa rized in Table 1 . The day-to-day variability of clear ances increased the higher the molecular weight. For dialysate protein concentrations values in the same order of magnitude were found: 16% for beta-2microglobulin, 12% for albumin, 15% for IgG and 26% for alpha-2-macroglobulin. In contrast to peritoneal clearances and dialysate concentrations of proteins, serum concentrations remained rather constant, with mean coefficients of variation of 8% for beta-2-microglobulin, 6% for albumin, 5% for IgG and 6% for alpha-2-macroglobulin. Drained volumes showed also less variability than protein clearances: mean coefficient of variation was 10% (range 7-12), irrespective of whether glucose 2.27% (84 occasions) or glucose 3.86% (25 occasions) was used. No differences in peritoneal clearances were found when different glucose concentrations were used. For example, mean albumin clearance in the 4 patients was 95.10 &mu;L/min with glucose 2.27% versus 97.42 with glucose 3.86% (not significant). Drained volumes did not correlate with protein clearances: rvalues ranged from 0.01 to 0.29.
A correlation was present in each patient between clearances of albumin and IgG (mean r=0.89; p<0.001), albumin and alpha-2-macroglobulin (mean r=0.80; p<0.001) and IgG and alpha-2-macroglobulin (mean r=0.85; p<0.001), but none of these protein clearances correlated with beta-2-microglobulin clearance (r-range: 0.09-0.32). Figure 2 illustrates peritoneal clearances of the 4 measured proteins in relation to their free diffusion coefficient in water (D2ow). In all patients on all consecutive days, this relationship appeared to be linear when plotted on a double logarithmic scale (correlation coefficients were always above 0.98). Therefore, it can be considered a power curve. The slope of this power curve represents the restriction of the peritoneum for the transport of macromolecules and can, therefore, be called the restriction coefficient. Mean values and coefficients of dayto-day variation of this restriction coefficient in each individual patient are summarized in Table 2 . Obviously, these coefficients were fairly constant during the 28day followup. In each patient, the restriction coefficient correlated with the ratio log alpha-2-macroglobulin clearance/log albumin clearance (r-range: 0.690.93; p<0.001). The coefficient of day-to-day variation of this ratio appeared to be low too: mean 6% (range 5 -10). No correlation was present between the restriction coefficient and the beta-2-microglobulin clearance (used as an indicator of peritoneal surface area).
DISCUSSION
In the present study, peritoneal clearances of serum proteins, as measured for beta-2-microglobulin, albumin, IgG and alpha-2-macroglobulin, appeared to show marked day-to-day variations in 4 stable CAPD patients during follow-up. The higher the molecular weight, the greater the variability. A possible explanation for this is given below. The established fluctuations could not be explained by the variability of the analysis of protein concentrations. Although variations in drained volume were somewhat higher than those calculated for the method of analysis, these could not have affected the alterations in protein clearances either, because the transport of macromolecules is not influenced by the effluent volume (5) . Similarly, when different glucose concentrations were used, no alterations in peritoneal transport of macromolecules were observed. This is in accordance with the results of Blumenkrantz et al. (5) . Although Twardowski et al. reported an effect of the length of the preceding exchange on total protein clearance of the following exchange, such an effect cannot explain the observed variability in the present study (27) . In their study, the length of the preceding exchange was either 75% or 300% of that of the following. In our study, this ranged from 36-86%. Furthermore, in another study using dwell times of exactly 4 hours with previous rinsing of the peritoneal cavity, a similar variability was found (20, 24) .
Our results confirm data from our previous studies (24,25), but are not in accordance with published data on dialysate protein concentrations (5-7, 21-23). According to these authors, protein concentrations in individual patients are more or less constant after a period varying from 2 months to 2 years, although interpatient variability may exist. However, in these studies no information was given on coefficients of variation, while the duration offollow-up was highly variable and only the total protein concentration or IgG were studied. Although 3 of our patients were on CAPD treatment for a short time, and had had no peritonitis, we have no reason to suppose that their protein clearance variability would disappear after a few more months, because the same profile ofvariability was found in the patient already treated with CAPD for 67 months and who had experienced several episodes of peritonitis. Furthermore, our previous studies with a longer follow-up and less frequent sampling also showed varying protein clearances in time, irrespective of the rate of peritonitis or the duration of CAPD treatment (24, 25) .
In theory, variations in lymphatic absorption of proteins from the peritoneal cavity could be one of the causes of the observed variability in our study. Although lymphatic absorption was not measured, we believe this is unlikely for 3 reasons: 1. when lymphatic absorption is important, a relationship should be present between drained volume and protein clearance, which could not be demonstrated in our study; 2. as lymphatic absorption has no influence on dialysate protein concentrations, the variability of protein clearances should be much higher than that of dialysate protein concentrations, if variability in lymphatic absorption is high (this was not the case); 3. lymphatic absorption of proteins is a process independent of molecular size (28) . This means that variations in lymphatic absorption should be equal for all proteins. Therefore, if variability of protein clearances are due to varying lymphatic absorption, the variations should be similar for all proteins measured. This could not be demonstrated. On the contrary, variability increased for proteins with a higher molecular weight.
On each day during the 109 studied patient days, correlations were established between clearances of albumin and IgG, albumin and alpha-2-macroglobulin, and IgG and alpha-2-macroglobulin. In contrast, beta-2-microglobulin clearance appeared not to correlate with any of these proteins. This may be explained by the fact that beta-2-microglobulin is a smaller molecule. As a consequence, its passage is much less hampered by the intrinsic permeability of the peritoneal membrane than larger molecules such as albumin, IgG a nd alpha-2-macroglobulin. Thus, transperitoneal transport ofbeta-2-microglobulin is probably mainly determined by the effective peritoneal surface area. This assumption is supported by the study of DiRaimondo et al. , who established significant relationships between peritoneal clearances ofbeta-2-microglobulin and the low molecular weight solutes creatinine and urea (29) . The probability that beta-2-microglobulin clearance mainly represents surface area implies that protein clearance ratios, when used as a measurement of the intrinsic peritoneal permeability, should not include this protein.
Several authors have tried to describe the relationship between peritoneal protein clearances and molecular weight mathematically. Most have recorded a power function: y=a.xb (30-33), except Kagan et al. , who established an exponential relationship (34). Boesken et al. reported an exponential relation when plotted on a double logarithmic scale (35) . In the present study, we could neither find a satisfying power relation nor an exponential fit for molecular weight and protein clearance. We thus searched for another protein property to relate the clearance to. It seemed plausible to take the Einstein-Stokes radius, because we previously described a relationship for dextrans between the reciprocal of the clearance and the EinsteinStokes radius (36) . However, no visually good fit was established when we used our data from the present study; large skews of the regression line were found especially at the position of alpha-2macroglobulin. These skews could possibly be explained by the fact that artefacts occur easily when one draws the reciprocal of a parameter. These artefacts become more pronounced for large mole cules with small protein clearance values, such as with alpha-2-macroglobulin. To avoid these problems, we related the peritoneal protein clearance to the free diffusion coefficient in water (D2o W)' as this parameter is inversely related to the Einstein-Stokes radius (37) . Furthermore, when diffusion is the main mechanism of transport for macromolecules, the protein clearance ratio has to be related in some way to D2oW. This appeared to be the case. The relationship between protein clearance and D2oW was linear when plotted on a double logarithmic scale, as dem onstrated for each individual patient and on each separate day. Therefore, it can be considered a power curve according to the equation C=a. D2o wb, in which C is clearance, a is a constant and b the'slope of the regression line. When we assume a mechanism of restricted diffusion for macromolecules through the peritoneum, this slope represents the restriction coefficient of the peritoneal membrane.
The fact that the variability in protein transport increased, the higher the molecular weight, while the restriction coefficient remained rather constant, seems contradictory. However, the higher the mo lecular weight, the more dependent the molecule is on the peritoneal restriction coefficient for passage across the peritoneum. As the restriction coefficient is the exponent of the diffusion coefficient, even small changes in this restriction coefficient have marked consequences for the clearances of these large mole cules.
Another way of analyzing intrinsic peritoneal permeability is to calculate the clearance ratio between a large and a small protein, e.g. alpha-2macroglobulin and albumin. This ratio, however , only represents intrinsic permeability when 2 conditions are met: 1. the effective peritoneal surface area is the same for both proteins -this is generally assumed (10,13); and 2. the shape of the graph of the relation between protein clearance and a protein property (in our case D2oW) is linear from alpha-2-macroglobulin to albumin. As this appeared to be the case on a double logarithmic scale, the logarithms of the clearances can be used for the calculation of the ratio. The log alpha-2-macroglobulin clearance/log albumin clearance ratio was highly correlated with the restriction coefficient. For both parameters, a low coefficient ofvariation was found. This indicates that the intrinsic permeability of the peritoneal membrane is fairly constant on the short term and cannot contribute much to day-to-day changes in protein clearances. This is not surprising. It would seem unlikely that daily changes in peritoneal structure would occur. Consequently, day-to-day variations in peritoneal protein clearances are mainly due to alterations in the effective peritoneal surface area.
When the effective surface area increases, it can be hypothesized that additional parts of the peritoneum are perfused that could contain peritoneal membrane with pores of a different size. This could lead to a higher or lower intrinsic permeability (38) . When this would occur, changes in the effective surface area can be expected to run parallel to changes in intrinsic permeability. To test this hypothesis, we used beta-2-microglobulin clearance as an indicator of surface area and the restriction coefficient as indicator of intrinsic permeability. No correlation was established between the 2 parameters, indicating that changes in surface area and intrinsic permeability of the peritoneal membrane occur independently.
Having demonstrated daily changes in surface area, the question arises by what mechanism the variability is caused. The effective surface area is determined by the number of perfused peritoneal capillaries and splanchnic blood flow. These are in turn influenced by vasoactive substances, such as cytokines and prostaglandins. Shaldon et al. hypothesized interleukin-l production by peritoneal macrophages, which stimulates prostaglandin synthesis and fibroblast formation, thus affecting peritoneal transport (39) . Certainly, more studies are needed to evaluate potential effects of these vasoactive substances in CAPD.
It can be concluded that marked day-to-day variations occur in peritoneal protein clearances as measured for beta-2-microglobulin, albumin, IgG and alpha-2-macroglobulin. The higher the molecular weight, the greater this variability. In all patients, a power function was established between protein clearance and D2oW. The exponent in this equation represents the peritoneal restriction coefficient, and thus the intrinsic permeability of the peritoneal membrane. This restriction coefficient appeared to be fairly constant on the short term. Therefore, daily changes in protein clearances are probably mainly caused by alterations in effective peritoneal surface area. Long-term follow-up of the restriction coefficient in individual patients might identify those at risk for the development of structural changes of the peritoneal membrane.
